Exclusive Report on Global Smart Syringes Market Analysis Report 2021 and Forecast to 2028 with different segments, Key players -Becton, Dickinson and Company, Gerresheimer AG, Baxter, Terumo Corporation, B. Braun Melsungen AG

Smart syringes are defined as type of medical devices which are engineered with safety mechanisms to prevent the reuse of syringes & regulate unsafe injection practices. These syringes are equipped with features to avoid needlestick injuries in a patient who uses these syringes and avoid transmission of blood-borne diseases like hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV). They cater to numerous applications including vaccination, drug delivery, and blood specimen collection.

The global smart syringes market growth is registered on account of the growing prevalence of target diseases, the rise in number of vaccinations, and the growth of geriatric population. Also, the increase in need to prevent hospital or clinic acquired infections will positively influence the market growth. Smart syringes are widely used in the field of vaccination, blood specimen collection, and drug delivery. Vaccination is an important form of prevention and it is used for administrating the antigenic substance to produce immunity to a particular disease. Numerous diseases such as smallpox & polio have been successfully exterminated through the vaccination.

Sample Copy of this Report @ https://qualiketresearch.com/request-sample/Smart-Syringes-Market/request-sample

As per the WHO smart syringes are designed to protect the person administering the injection & to prevent the syringe from being used more than once. Government & NGO are taking initiatives to promote the awareness regarding safety & precaution of syringes in different developing countries across the globe. For instance, World Health Organization had launched a policy on injection safety & to block the use of unsafe injections. New WHO safety guidelines & policy offers detailed recommendations highlighting the value of safety features for syringes, including devices which protect health workers against accidental needle injury & consequent exposure to infection.

High cost of smart syringes, especially passive safety syringes as well as lack of awareness in developing nations, and alternative drug delivery methods are expected to hinder the global smart syringes market growth.

Impact of COVID-19

Volume of smart syringes to be used in upcoming years is anticipated to witness a sharp increase, due to the COVID-19 immunization programs which are pre-planned across the globe. COVID-19 infection has already proven its ability to create medical equipment shortages like supply of face masks, gowns, and PPE (personal protective equipment) within early days of the crisis. Thus, to overcome such supply chain issues, governments & private organizations have already started manufacturing of syringes, as they are one of the essential components of vaccine delivery. This demand for global vaccination against Covid-19 is wholly prepared to fuel smart syringe manufacturing throughout the pandemic period.

Market Segmentation

The Global Smart Syringes Market is segmented into product type such as Auto-disable syringes, Active safety syringes, and Passive safety syringes, by application such as Vaccination, Blood Specimen Collection, and Drug delivery. Further, market is segmented into Hospitals & HMOs, Family practices (Physicians), Diabetic patients, Psychiatrics and, Others.

Also, the Global Smart Syringes Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Regional Analysis

The North America is expected to hold highest market share in the global smart syringe market followed by Europe, and Asia-Pacific. Europe is the second largest market and it is projected to be the most significant revenue contributor over the forecast period. Due to the several developments in the healthcare industry in the countries like Germany, France, and Spain. The APAC is expected to be an emerging market for the smart syringes market, and is anticipated to register highest CAGR in throughout the forecasted period, due to the increase demand for minimal invasive medical procedure & growing healthcare expenditure in the region.

Key Players

Some key operating players are listed in this report such as Becton, Dickinson and Company, Gerresheimer AG, Baxter, Terumo Corporation, B. Braun Melsungen AG, AdvaCare Pharma, Cardinal Health, Parker Hannifin Corp, Numedico Technologies Pty Ltd, Retractable Technologies, Inc., etc.

Market Taxonomy

By Product Type

• Auto-disable syringes
• Active safety syringes
• Passive safety syringes

By Application

• Vaccination
• Blood Specimen Collection
• Drug delivery

By End User

• Hospitals & HMOs
• Family practices (Physicians)
• Diabetic patients
• Psychiatrics
• Others

By Region

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

Get Discount copy of this Report @ https://qualiketresearch.com/request-sample/Smart-Syringes-Market/ask-for-discount

Vishal Thakur
Research Support Specialist
QualiKet Research
6060 N Central Expy #500, TX 75204, U.S.A
Email: sales@qualiketresearch.com
Website: https://qualiketresearch.com

QualiKet Research is a leading Market Research and Competitive Intelligence partner helping leaders across the world to develop robust strategy and stay ahead for evolution by providing actionable insights about ever changing market scenario, competition and customers. QualiKet Research is dedicated to enhancing the ability of faster decision making by providing timely and scalable intelligence. We use different intelligence tools to come up with evidence that showcases the threats and opportunities which help our clients outperform their competition.

This release was published on openPR.